Jtekt India Rights Issue 2025 vs Valiant Laboratories Limited Rights Issue 2025

Comparison between Jtekt India Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Jtekt India Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025. Jtekt India Rights Issue 2025 is listed on BSE, NSE while Valiant Laboratories Limited Rights Issue 2025 is listed on BSE, NSE.

 Jtekt India LimitedValiant Laboratories Limited
LogoJtekt India Rights Issue 2025 LogoValiant Laboratories Limited Rights Issue 2025 Logo
Listing AtBSE, NSEBSE, NSE
Terms of Payment

On Application: Rs 108.10

As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application.

Entitlement1 Rights Equity Share(s) for every 11 fully paid-up Equity Shares held on Record Date1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarKfin Technologies Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Jtekt India Rights Issue 2025 rights issue is ₹249.89 Crores, whereas Valiant Laboratories Limited Rights Issue 2025 rights issue size is ₹81.47 Crores.

 Jtekt India LimitedValiant Laboratories Limited
Issue Size2,31,16,407 shares1,08,62,500 shares
Issue Size (Amount)₹249.89 Crores₹81.47 Crores
Issue Price₹108.1 per share₹75 per share
Face Value₹1 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Jtekt India Rights Issue 2025 is Jul 25, 2025 while record date of Valiant Laboratories Limited Rights Issue 2025 is Jul 19, 2025.

 Jtekt India LimitedValiant Laboratories Limited
Record DateJul 25, 2025Jul 19, 2025
Credit of Rights EntitlementsJul 28, 2025Jul 21, 2025
Bid/Offer Opens OnAug 04, 2025Jul 28, 2025
Renunciation of Rights EntitlementsAug 07, 2025Aug 05, 2025
Bid/Offer Closes OnAug 12, 2025Aug 08, 2025
Deemed Date of AllotmentAug 14, 2025Aug 11, 2025
Credit DateAug 14, 2025Aug 12, 2025
Listing DateAug 14, 2025Aug 13, 2025

Financials details

Comparison of Jtekt India Rights Issue 2025 and Valiant Laboratories Limited Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Jtekt India LimitedValiant Laboratories Limited
Financial

Jtekt India Limited Financial Information (Restated Consolidated)

Jtekt India Limited's revenue increased by 7% and profit after tax (PAT) dropped by 31% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue2,409.012,256.98
Profit After Tax73.45105.91
Net Worth879.88821.68
Reserves and Surplus854.45796.25
Amount in ₹ Crore

Valiant Laboratories Limited Financial Information (Restated Consolidated)

Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue133.38182.06
Profit After Tax-2.200.32
Net Worth234.31236.86
Reserves and Surplus190.86193.41
Amount in ₹ Crore

Compare with others

Compare:

Jtekt India Rights Issue 2025 Vs Valiant Laboratories Limited Rights Issue 2025